Inspire Medical Systems
(NYSE) INSP
Inspire Medical Systems Financials at a Glance
Market Cap
$1.28B
Revenue (TTM)
$915.25M
Net Income (TTM)
$131.14M
EPS (TTM)
$4.47
P/E Ratio
9.90
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$43.37
Volume
926,871.289
Open
$43.57
Price
$43.37
Volume
926,871.289
Open
$43.57
Previous Close
$43.35
Daily Range
$43.03 - $45.09
52-Week Range
$43.03 - $161.88
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$43.37
Volume
926,871.289
Open
$43.57
Previous Close
$43.35
Daily Range
$43.03 - $45.09
52-Week Range
$43.03 - $161.88
INSP News
INSP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inspire Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,333
CEO
Timothy P. Herbert, MBA
Website
www.inspiresleep.comHeadquarters
Golden Valley, MN 55416, US
INSP Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
6%
Net Income Margin
14%
Return on Equity
18%
Return on Capital
6%
Return on Assets
14%
Earnings Yield
10.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.28B
Shares Outstanding
28.81M
Volume
926.87K
Avg. Volume
1.23M
Financials (TTM)
Gross Profit
$778.76M
Operating Income
$50.95M
EBITDA
$64.91M
Operating Cash Flow
$116.98M
Capital Expenditure
$38.50M
Free Cash Flow
$78.48M
Cash & ST Invst.
$308.27M
Total Debt
$32.16M
Inspire Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$204.58M
+1.6%
Gross Profit
$176.91M
+3.7%
Gross Margin
86.47%
N/A
Market Cap
$1.28B
N/A
Market Cap/Employee
$1.02M
N/A
Employees
1,246
N/A
Net Income
$11.29M
-477.5%
EBITDA
$3.99M
+156.1%
Quarterly Fundamentals
Net Cash
$254.28M
-24.2%
Accounts Receivable
$105.09M
+13.5%
Inventory
$166.24M
+66.7%
Long Term Debt
$29.55M
-6.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
14.39%
N/A
Return on Invested Capital
6.24%
N/A
Free Cash Flow
$3.12M
+120.7%
Operating Cash Flow
$12.85M
+291.7%